A Single-Arm Phase II Clinical Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma

Category Primary study
ConferenceAnnual Meeting of the Society of Surgical Oncology, SSO 2026
Year 2026
This article has no abstract
Epistemonikos ID: bad6407f4e0a40508d7c11145f4f03e3c2df7ee0
First added on: May 18, 2026